168 related articles for article (PubMed ID: 24485294)
21. [Epidemiology of prostate cancer in the Limousin area].
Druet-Cabanac M; Colombeau P; Preux PM; Paulhac P; Vergnenegre A; Dumas JP
Prog Urol; 2002 Apr; 12(2):226-31. PubMed ID: 12108336
[TBL] [Abstract][Full Text] [Related]
22. Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013.
Tempo J; Logan C; O'Callaghan M; Kahokehr A; Kichenadasse G; D'Onise K; Foreman D
Cancer Epidemiol; 2020 Apr; 65():101692. PubMed ID: 32151978
[TBL] [Abstract][Full Text] [Related]
23. [Prostate cancer incidence and mortality trends in France from 1980 to 2011].
Grosclaude P; Belot A; Daubisse Marliac L; Remontet L; Leone N; Bossard N; Velten M;
Prog Urol; 2015 Jul; 25(9):536-42. PubMed ID: 26043950
[TBL] [Abstract][Full Text] [Related]
24. [Trends in urologic neoplasm mortality and incidence (prostate, bladder, and kidney). Soria, 1950-1988].
Ruiz Liso JM; Sanz Anquela JM; Alfaro Torres J; García Pérez MA; Dodero de Solano E
Arch Esp Urol; 1989; 42(6):532-8. PubMed ID: 2817983
[TBL] [Abstract][Full Text] [Related]
25. Survival of Danish cancer patients 1943-1987. Male genital organs.
Møller H; Friis S; Kjaer SK
APMIS Suppl; 1993; 33():122-36. PubMed ID: 8512735
[TBL] [Abstract][Full Text] [Related]
26. Cancer incidence and mortality in France over the period 1978-2000.
Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
[TBL] [Abstract][Full Text] [Related]
27. Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999-2020.
Cho S; Park WJ
Investig Clin Urol; 2024 Jan; 65(1):23-31. PubMed ID: 38197748
[TBL] [Abstract][Full Text] [Related]
28. Social inequality and incidence of and survival from male genital cancer in a population-based study in Denmark, 1994-2003.
Marså K; Johnsen NF; Bidstrup PE; Johannesen-Henry CT; Friis S
Eur J Cancer; 2008 Sep; 44(14):2018-29. PubMed ID: 18667299
[TBL] [Abstract][Full Text] [Related]
29. Trends in mortality from urologic cancers in Europe, 1970-2008.
Bosetti C; Bertuccio P; Chatenoud L; Negri E; La Vecchia C; Levi F
Eur Urol; 2011 Jul; 60(1):1-15. PubMed ID: 21497988
[TBL] [Abstract][Full Text] [Related]
30. Pattern of urological malignancy in Zambia. A hospital-based histopathological study.
Elem B; Patil PS
Br J Urol; 1991 Jan; 67(1):37-9. PubMed ID: 1847087
[TBL] [Abstract][Full Text] [Related]
31. Mortality Trends from Urologic Cancers in Europe over the Period 1980-2017 and a Projection to 2025.
Bertuccio P; Santucci C; Carioli G; Malvezzi M; La Vecchia C; Negri E
Eur Urol Oncol; 2021 Oct; 4(5):677-696. PubMed ID: 34103280
[TBL] [Abstract][Full Text] [Related]
32. Incidence of kidney, bladder, and prostate cancers in Korea: An update.
Song W; Jeon HG
Korean J Urol; 2015 Jun; 56(6):422-8. PubMed ID: 26078838
[TBL] [Abstract][Full Text] [Related]
33. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
Saito K; Kihara K
Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
[TBL] [Abstract][Full Text] [Related]
34. [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
Ouedraogo S; Traore MT; Kambire JL; Ouedraogo S; Bere B; Kabore AF
Bull Cancer; 2019 Oct; 106(10):868-874. PubMed ID: 31350015
[TBL] [Abstract][Full Text] [Related]
35. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
Gilliland F; Becker TM; Smith A; Key CR; Samet JM
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
[TBL] [Abstract][Full Text] [Related]
36. [Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990].
Grosclaude P; Menegoz F; Schaffer P; Macé Lesec'h J; Arveux P; Le Mab G; Soulié M; Villers A
Prog Urol; 1997 Sep; 7(4):647-54. PubMed ID: 9410328
[TBL] [Abstract][Full Text] [Related]
37. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
Barocas DA; Rabbani F; Scherr DS; Vaughan ED
BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
[TBL] [Abstract][Full Text] [Related]
38. Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank.
Huang J; Huang D; Ruan X; Huang J; Xu D; Heavey S; Olivier J; Na R
Cancer Med; 2023 Feb; 12(3):3468-3476. PubMed ID: 35975633
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology of tumors of the testis].
Mandron E; Schill H
Arch Anat Cytol Pathol; 1992; 40(4):190-4. PubMed ID: 1294047
[TBL] [Abstract][Full Text] [Related]
40. Urological Cancers in French Overseas Territories: A Population-Based Cancer Registry Pooled Analysis in Martinique, Guadeloupe and French Guiana (2007-2014).
Deloumeaux J; Bhakkan-Mambir B; Desroziers L; Plenet J; Peruvien J; Chatignoux É; Belliardo S; Macni J; Ulric-Gervaise S; Véronique-Baudin J; Joachim C
J Epidemiol Glob Health; 2022 Sep; 12(3):232-238. PubMed ID: 35041179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
